Evidence map›Paper›PMID 16081545›Full record

Trial reportAmerican journal of respiratory and critical care medicine2005

Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection.

Homayoun Shams, Stephen E Weis, Peter Klucar, Ajit Lalvani, Patrick K Moonan, Janice M Pogoda, Katie Ewer, Peter F Barnes

Open access · greenAbstract readClinical TrialComparative Study
In one paragraph

Trial report in American journal of respiratory and critical care medicine, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 124 citations in OpenAlex.

  1. Trial
  2. Article
  3. Cracking the antigenic code of mycobacteria: CFP-10/ESAT-6 tuberculosis skin test and misleading results.Journal of clinical tuberculosis and other mycobacterial diseases · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Tuberculosis contact investigation in a high-burden setting: house or household?The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2012
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 2 countries.

Homayoun ShamsCPIDC, University of Texas Health Center, 11937 U.S. Highway 271, Tyler, TX 75708-3154. peter.barnes@uthct.edu.
Stephen E Weis
Peter Klucar
Ajit Lalvani
Patrick K Moonan
Janice M Pogoda
Katie Ewer
Peter F Barnes
University of North Texas · US

Funding

TRANSMISSION DYNAMICS OF TB ALONG THE U.S.-MEXICO BORDERR01AI044935 · NIAID · UNIVERSITY OF TEXAS HLTH CTR AT TYLER · PI BARNES, PETER F. · 2000 to 2004
$1.2M
NIAID NIH HHS AI44935ODCDC CDC HHS U90/CCU620916
6 · The paper itself

Abstract

rationaleDiagnosis of latent tuberculosis infection (LTBI) is currently based on the tuberculin skin test. The enzyme-linked immunospot assay (ELISPOT) is a new blood test to diagnose LTBI.

objectiveTo compare the ELISPOT and the tuberculin skin test for detecting LTBI in contacts of patients with tuberculosis.

methodsProspective study of 413 contacts of patients with tuberculosis. MEASUREMENTS AND MAIN

resultsBecause there is no gold standard for LTBI, the sensitivity and specificity of the ELISPOT and tuberculin skin test cannot be directly measured. For each contact, we therefore estimated the likelihood of having LTBI by calculating a contact score that quantified exposure to and infectiousness of the index case. We analyzed the relationship of contact score to ELISPOT and tuberculin skin test results. The likelihood of a positive ELISPOT (p = 0.0005) and a tuberculin skin test (p = 0.01) increased significantly with rising contact scores. The contact score was more strongly related to the ELISPOT than to the tuberculin skin test results, although this difference was not statistically significant. Among U.S.-born persons and those who were not vaccinated with bacille Calmette-Guérin, approximately 30% had positive ELISPOT or tuberculin skin test results. Foreign-born, bacille Calmette-Guérin-vaccinated persons were significantly more likely to have a positive tuberculin skin test than a positive ELISPOT result (p < 0.0001).

conclusionsCompared with the tuberculin skin test, the ELISPOT appears to be at least as sensitive for diagnosis of LTBI in contacts of patients with tuberculosis.

Indexed as

Tuberculin TestAdolescentAdultBCG VaccineCarrier StateChildContact TracingEmigration and ImmigrationEnzyme-Linked Immunosorbent AssayFemaleHumansMaleMiddle AgedSensitivity and SpecificityTuberculosisBCG Vaccine

Identifiers

PMID16081545
PMCPMC2718400
OpenAlexW2139452364

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.